Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer (Q84895408)
Jump to navigation
Jump to search
scientific article published on 06 September 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer |
scientific article published on 06 September 2011 |
Statements
Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer (English)
Yasuhide Yamada
Hiroshi Matsumoto
Yasushi Ichikawa
Ayumu Goto
Ken Kato
Tetsuya Hamaguchi
Yasuhiro Shimada
6 September 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference